509 filings
25-NSE
The Nasdaq Stock Market LLC
25 Apr 24
Exchange delisting
9:09am
8-K
PBLA
Panbela Therapeutics, Inc.
22 Apr 24
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
8:02am
S-1
PBLA
Panbela Therapeutics, Inc.
IPO registration
18 Apr 24
4:31pm
8-K
PBLA
Panbela Therapeutics, Inc.
17 Apr 24
Panbela Announces Transfer to OTCQB Market
8:36am
EFFECT
PBLA
Panbela Therapeutics, Inc.
17 Apr 24
Notice of effectiveness
12:15am
DEF 14A
PBLA
Panbela Therapeutics, Inc.
Definitive proxy
4 Apr 24
4:17pm
EFFECT
PBLA
Panbela Therapeutics, Inc.
3 Apr 24
Notice of effectiveness
12:15am
S-1
PBLA
Panbela Therapeutics, Inc.
IPO registration
29 Mar 24
5:24pm
POS AM
PBLA
Panbela Therapeutics, Inc.
29 Mar 24
Prospectus update (post-effective amendment)
5:08pm
10-K
2023 FY
PBLA
Panbela Therapeutics, Inc.
Annual report
26 Mar 24
4:15pm
8-K
PBLA
Panbela Therapeutics, Inc.
26 Mar 24
Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results
4:12pm
PRE 14A
PBLA
Panbela Therapeutics, Inc.
Preliminary proxy
25 Mar 24
4:15pm
8-K
PBLA
Panbela Therapeutics, Inc.
7 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:01am
8-K
PBLA
Panbela Therapeutics, Inc.
15 Feb 24
Regulation FD Disclosure
8:05am
SC 13G/A
Lind Global Fund II LP
13 Feb 24
Panbela Therapeutics / Lind Global Fund II ownership change
8:10pm
8-K
PBLA
Panbela Therapeutics, Inc.
13 Feb 24
Departure of Directors or Certain Officers
5:24pm
8-K
PBLA
Panbela Therapeutics, Inc.
1 Feb 24
Panbela Announces Closing of Approximately $9.0 Million Public Offering
7:15am
424B4
PBLA
Panbela Therapeutics, Inc.
30 Jan 24
Prospectus supplement with pricing info
5:28pm
8-K
PBLA
Panbela Therapeutics, Inc.
29 Jan 24
Panbela Announces Pricing of Approximately $9.0 Million Public Offering
6:21am
EFFECT
PBLA
Panbela Therapeutics, Inc.
29 Jan 24
Notice of effectiveness
12:15am